Status:
COMPLETED
Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial
Lead Sponsor:
Taipei Medical University
Conditions:
Oral Mucositis
Eligibility:
All Genders
20-100 years
Phase:
NA
Brief Summary
The investigators plan to conduct a 3-year pioneering care research project for mucositis in cancer patients. These include: (1) an analysis of the incidence and severity of mucositis, severity, treat...
Detailed Description
Mucositis is common among cancer patients receiving radiotherapy and chemotherapy. A total of 80-100% of the patients are suffering from the mucositis pain; their regular dieting is disturbed, nutriti...
Eligibility Criteria
Inclusion
- age≧20 years old
- diagnosed as head and neck cancer patients
- Plan to Receive radiation therapy
- Consciousness, ability to complete research assessment and willing to participate in research
- Patients can be communicated in Mandarin and Taiwanese, and complete the questionnaire on their own or with the help of researchers.
Exclusion
- History of allergic to honey, propolis, various pollen, alcohol
- People with mental disorders or cognitive dysfunction
- Diabetes mellitus
- Critical of end of life patient
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04382079
Start Date
April 8 2020
End Date
April 15 2022
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University
Taipei County, Taiwan, 110